Health Canada is advising consumers that Sanofi-aventis Canada Inc. is recalling two lots of children's Allerject distributed starting June 1, 2015, due to potential device defect affecting the delivery of drug to the patient. As a result of a manufacturing defect with the needle, the device may not deliver the epinephrine needed for emergency treatment of serious allergic reactions (anaphylaxis), which can pose serious health risks to patients. Anaphylaxis may cause death.

Parents and caregivers of children who use Allerject are urged to check the lot number and return affected product to their pharmacy for replacement.

Shoppers Drug Mart has quarantined this product in our distribution centres and directed all stores to remove it from our shelves immediately.

Product affected:

Product Name : ALLERJECT 0.15MG

UPC : 0065914112164 and 0065914112171

Product strength : 0.15mg/0.15mL

DIN: 02382059

Lot : 2857505 and 2857508

Expiry Date : Sep-2016

What you should do:

  • The parents and caregivers of children using this product are advised to check the lot numbers of their Allerject (0.15 mg / 0.15 mL auto-injector) and return all affected product to their pharmacy for replacement auto-injectors with the same dosage of epinephrine.
  • They should also speak with their pharmacists to ensure they properly understand how to use the replacement auto-injector if it is different from the one they have been using.
  • Parents and caregivers of children using this product who have concerns about their child's health should speak to their healthcare professional.
  • Report any adverse events to Health Canada .

For more information on this recall, visit: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53781a-eng.php

Customer inquiries can be directed to Sanofi-aventis Canada's customer service line at 1-800-265-7927.
distributed by